Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and WebcastConference Call
CELC Stock | USD 12.10 0.45 3.59% |
About 67% of Celcuity LLC's investor base is looking to short. The analysis of the overall investor sentiment regarding Celcuity LLC suggests that many traders are alarmed. The current market sentiment, together with Celcuity LLC's historical and current headlines, can help investors time the market. In addition, many technical investors use Celcuity LLC stock news signals to limit their universe of possible portfolio assets.
Celcuity |
MINNEAPOLIS, May 08, 2024 -- Celcuity Inc. , a clinical-stage biotechnology company pursuing development of targeted...
Read at globenewswire.com
Celcuity LLC Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Celcuity LLC can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Celcuity LLC Fundamental Analysis
We analyze Celcuity LLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Celcuity LLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Celcuity LLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Celcuity LLC is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Celcuity LLC Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Celcuity LLC stock to make a market-neutral strategy. Peer analysis of Celcuity LLC could also be used in its relative valuation, which is a method of valuing Celcuity LLC by comparing valuation metrics with similar companies.
Peers
Celcuity LLC Related Equities
CSBR | Champions Oncology | 7.97 | ||||
ACRV | Acrivon Therapeutics, | 3.00 | ||||
MLYS | Mineralys Therapeutics, | 1.56 | ||||
AVTE | Aerovate Therapeutics | 1.19 | ||||
MNOV | MediciNova | 0.94 | ||||
ANEB | Anebulo Pharmaceuticals | 0.77 | ||||
EWTX | Edgewise Therapeutics | 0.53 | ||||
ANTX | AN2 Therapeutics | 0.74 | ||||
MOLN | Molecular Partners | 1.87 | ||||
ADAG | Adagene | 2.86 | ||||
ANAB | AnaptysBio | 4.07 | ||||
IKNA | Ikena Oncology | 4.32 | ||||
RZLT | Rezolute | 8.11 | ||||
CCCC | C4 Therapeutics | 9.63 | ||||
HOWL | Werewolf Therapeutics | 9.76 |
Complementary Tools for Celcuity Stock analysis
When running Celcuity LLC's price analysis, check to measure Celcuity LLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celcuity LLC is operating at the current time. Most of Celcuity LLC's value examination focuses on studying past and present price action to predict the probability of Celcuity LLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celcuity LLC's price. Additionally, you may evaluate how the addition of Celcuity LLC to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |